Currier R. Dugoff L, Norton ME.: Maternal serum screening for Down syndrome in twin pregnancies: Parameters from cohort of affected pregnancies. Accepted for presentation at the Annual Meeting of the International Society of Prenatal Diagnosis, Singapore : 2019.
Boelig RC. Dugoff L, Roman-Carmargo A, Berghella V, Ludmir J:: Predicting asmptomatic cervical dilation in pregnant patients with short mid-trimester cervical length: A secondary analysis of a randomized controlled trial ACTA Obstet Gynecol Scand 98 (6): 761-768,2019.
Hopkins MK, Koelper N, Bender W, Durnwald C, Sammel M, Dugoff L: Cell-free DNA and risk for gestational diabetes Am J Obstet Gynecol Submitted : 2019.
Hopkins MK, Dugoff L, Durnwald C, Havrilesky LJ, Dotters-Katz S: Cell-free DNA for Down syndrome screening in obese women: Is it a cost-effective strategy?
Obstet Gynecol Submitted : 2019.
Pritchard AB, Grand K, Hopkins M, Schindewolf E, Dugoff L, Bhoj E.: What not to expect when you’re expecting: unusual cases of placental mosaicism detected on non-invasive prenatal screening
Am J Med Genet Submitted : 2019.
Bender W, Koelper N, Sammel MD, Dugoff L.: Association of Fetal Fraction of Cell Free DNA and Hypertensive Disorders of Pregnancy.
Am J Perinatol 36 (3): 311-316,2019.
Hopkins MK, Dugoff L, Kuller JA:: Congenital heart disease: prenatal diagnosis and genetic associations.
Obstet Gynecol Surv Accepted for publication : 2019.
Capalbo A, Chokoshvili D, Dugoff L, Franasiak L, Gleicher N, Pennings G, Simon C: Should the reproductive risk of a couple aiming to conceive be tested in the contemporary clinical context?
Fertil Steril 111 (2): 229-238,2019.
Hopkins M, Dugoff L, Durnwald C, Havrilesky L, Dotters-Katz S: Cell-free DNA for Down syndrome screening in morbidly obese women: is it a cost-effective strategy? Annual Society for Maternal Fetal Medicine meeting, Las Vegas, NV : 2019.
Patel S, Dugoff L.: Cell-free DNA screening
Perinatal Genetics. 1st edition. Elsevier, St. Louis, MO, : 2019.